Role of GSTM1 and GSTT1 polymorphism: Susceptibility to oral submucous fibrosis in the north indian population

Oncology

Volumn 79, Issue 3-4, 2011, Pages 181-186

  Agrawal, Deepa ^a   Gupta, Shalini ^b   Agarwal, Deepti ^b   Gupta, Om Prakash ^b   Agarwal, Mohit ^a,b  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Glutathione s transferases; GSTM1; GSTT1; Oral submucous fibrosis; Polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; PRIORITY JOURNAL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INDIA; MALE; ORAL SUBMUCOUS FIBROSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 79952060679     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318533     Document Type: Article

References (44)

1. International Agency for Research on Can-cer: Betel Quid and Areca Nut Chewing and Some Areca Nut Derived Nitrosamines. Lyon, IARC; 2004, pp 123-129.
2. Rothman K, Keller A: The effect of joint ex-posure to alcohol and tobacco on risk of can-cer of the mouth and pharynx. J Chronic Dis 1972; 25: 711-716.
3. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al: Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-3287.
4. Day GL, Blot WJ, Austin DF: Racial differ-ences in risk of oral and pharyngeal cancer: alcohol, tobacco and other determinants. J Natl Cancer Inst 1993; 85:465-473. (Pubitemid 23084091)
5. Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Pindborg JJ, Metha FS: Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing. J Oral Pathol Med 1995; 24:145-152.
6. Seedat HA, van Wyk CW: Betel-nut chewing and submucous fibrosis in Durban. S Afr Med J 1988; 74:568-571. (Pubitemid 19031665)
7. Zain RB, Ikeda N, Razaki H, Axell T, Majid ZA, Gupta PC, et al: A national epidemio-logical survey of oral mucosal survey of oral mucosal lesions in Malaysia. Community Dent Oral Epidemol 1997; 25: 377-383. (Pubitemid 127534602)
8. Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW: Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med 1994; 23: 65-69.
9. Ranganathan K, Devi MU, Joshua E, Kiran-kumar K, Saraswathi TR: Oral submucous fibrosis: a case-control study in Chennai, South India. J Oral Pathol Med 2004; 33:274-277. (Pubitemid 38579445)
10. Chiu CJ, Chang ML, Chiang CP, Hahn LJ, Hsieh LL, Chen CJ: Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. Cancer Ep-idemiol Biomarkers Prev 2002; 11:646-653.
11. Jacob BJ, Straif K, Thomas G, Ramdas K, Mathew B, Zhang ZF, et al: Betel quid with-out tobacco as a risk factor for oral precan-cers. Oral Oncol 2004; 40:697-704. (Pubitemid 38686906)
12. Shah N, Sharma PP: Role of chewing and smoking habits in the etiology of oral sub-mucous fibrosis (OSF): a case control study. J Oral Pathol Med 1998; 27:475-479. (Pubitemid 28514883)
13. Caniff JP, Harvey W, Harris M: Oral submu-cous fibrosis: its pathogenesis and manage-ment. Br Dent J 1986; 160:429-434.
14. Auluck A, Rosin MP, Zhang L, Sumanth KN: Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature. J Can Dent Assoc 2008; 74:735-740.
15. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K: CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combina-tions are associated with the increased risk of the laryngeal squamous cell carcinoma. Mu-tat Res 2005; 574: 12-23.
16. Bartsch H, Nair U, Risch A, Rojas M, Wik-man H, Alexandrov K: Genetic polymor-phism of CYP genes, alone or in combina-tion, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000; 9: 3-28. (Pubitemid 30062906)
17. Boffetta P, Hashibe M: Alcohol and Cancer. Lancet Oncol 2006; 7:149-156. (Pubitemid 43159501)
18. Geisler SA, Olshan AF: GSTM1, GSTT1 and risk of squamous cell carcinoma of head and neck: a mini-huge review. Am J Epidemiol 2001; 154:95-105. (Pubitemid 32643123)
19. Brennan P, Boffetta P: Mechanistic consider-ations in the molecular epidemiology of head and neck cancer. IARC Sci Publ 2004; 393-314.
20. Parl FF: Glutathione S-transferase genotypes and cancer risk. Cancer Lett 2005; 221:123-129. (Pubitemid 40460398)
21. Hashibe M, Brenman P, Strange RC, et al: Meta- and pooled analysis of GSTM1, GSTT1, GSTP1 and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003; 12:1509-1517 (Pubitemid 38031756)
22. Peters ES, McClean MD, Liu M, Eisen EA, Mueller N, Kelsey KT: The ADHIC polymor-phism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epide-miol Biomarkers Prev 2005; 14:476-482. (Pubitemid 40270114)
23. Gambashidze K, Kipiani N, Topurize M: Biophysical and biochemical parameters of organism during experimental malignant tumour growth. Am Biomed Res Educ 2002; 2: 196-203.
24. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ: Isoenzyme(s) of glutathione transferase (class μ) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis 1990; 11: 33-36. (Pubitemid 20050732)
25. Naveen AT, Adithan C, Padmaja N: Gluta-thione S-transferases M1 and T1 null geno-type distribution in South Indians. Eur J Clin Pharmacol 2004; 60: 403-406. (Pubitemid 39214893)
26. Gronau S, Koenig-Greger D, Jerg M, Riech-elmann H: Gene Polymorphism in detoxifi-cation enzymes as susceptibility factor for head and neck cancer? Otolaryngol Head Neck Surg 2003; 128:674-680. (Pubitemid 41123130)
27. Srivastava DS, Mandhani A, Mittal B, Mittal RD: Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU Int 2005; 95:170-173. (Pubitemid 350020890)
28. Sambrook J, Russel DW: Molecular Cloning: A Laboratory Manual, ed 3. New York, Cold Spring Harbour, 2001.
29. Tilakarante WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S: Oral submu-cous fibrosis: review on aetiology and patho-genesis. Oral Oncol 2006; 42: 561-568. (Pubitemid 43965004)
30. Pindborg JJ, Chawla TN, Srivastava AN, Gupta D: Epithelial changes in oral submu-cous fibrosis. Acta Odontol Scand 1965; 23: 277-286.
31. Shiau YY, Kwan HW: Submucous fibrosis in Taiwan. Oral Surg Oral Med Oral Pathol 1979; 47:453-457. (Pubitemid 10205237)
32. Mani NJ, Singh B: Studies on oral submu-cous fibrosis. III. epithelial changes. Oral Surg Oral Med Oral Pathol 1976; 41: 203-214.
33. Wahi PN, Luthra UK, Kapur VL: Submucous fibrosis of the oral cavity: histomporpholog-ical studies. Br J Cancer 1966; 20:676-687.
34. Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB: Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among In-dians: tobacco exposure as a risk modulator. Carcinogenesis 2007; 28:1455-1462. (Pubitemid 47241795)
35. Bathi RJ, Rao R, Mutalik S: GST null geno-type and antioxidants: risk indicators for oral pre-cancer and cancer. Indian J Dent Res 2009; 20:298-203.
36. Nair UJ, Nair J, Mathew B, Bartsch H: Gluta-thione S-transferase M1 and T1 null geno-types as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis 1999; 20:743-748. (Pubitemid 29191854)
37. Pal M, Chaudhuri SR, Jadav A, Banerjee S, Paul RR Dutta PK, et al: Quantitative di-mensions of histopathological attributes and status of GSTM1-GSTT1 in oral submucous fibrosis. Tissue Cell 2008; 40:425-435.
38. Oshan AF Weissler MC, Watson MA, Bell DA: GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epide-mol Biomarkers Prev 2000; 9: 185-191. (Pubitemid 30111942)
39. Trizna Z, Clayman GL, Spitz MR, Briggs KL, Goepfert H: Glutathione s-transferase geno-types as risk factors for head and neck can-cer. Am J Surg 1995; 170: 499-501.
40. Lin HJ, Han CY, Bernstein DA, Hsiao W, Lin BK, Hardy S: Ethnic distribution of the glu-tathione transferase Mu 1-1 (GSTM1) null genotype in 1,473 individuals and applica-tion to bladder cancer susceptibility. Carci-nogenesis 1994; 15:1077-1081. (Pubitemid 24156914)
41. Zhao B, Lee EJ, Wong JY, Yeoh PN, Gong NH: Frequency of mutant CYP1A1, NAT2 and GSTM1 alleles in normal Indians and Malays. Pharmacogenetics 1995; 5:275-280.
42. Lee EJ, Wong JY, Yeoh PN, Gong NH: Gluta-thione S-transferase-theta (GSTT1) genetic polymorphism among Chinese, Malays and Indians in Singapore. Pharmacogenetics 1995; 5:332-334.
43. Nelson HH, Wiencke JK, Christiani DC, Cheng T J, Zuo ZF, et al: Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis 1995; 16:1243-1245.
44. Strange RC, Fryer AA: The glutathione S-transferases: influence of polymorphism on cancer susceptibility; in Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P (eds): Metabolic Polymorphisms and Susceptibility to Cancer. Lyon, IARC, 1999, pp 231-249.